NASDAQ:RUBY - Rubius Therapeutics Earnings Date, Estimates & History Sign in or create an account to add this stock to your watchlist. Get Started $16.78 +0.39 (+2.38 %) (As of 05/21/2019 04:00 PM ET)Previous Close$16.39Today's Range$15.75 - $17.1652-Week Range$12.70 - $33.01Volume225,462 shsAverage Volume300,088 shsMarket Capitalization$1.34 billionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsChartEarningsInsider TradesInstitutional OwnershipHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Earnings Rubius Therapeutics (NASDAQ:RUBY) Earnings History and Estimates ChartRubius Therapeutics (NASDAQ:RUBY) Earnings Estimates2019 EPS Consensus Estimate: ($2.15)QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20191($0.50)($0.50)($0.50)Q2 20192($0.55)($0.45)($0.50)Q3 20192($0.61)($0.49)($0.55)Q4 20192($0.68)($0.52)($0.60)Rubius Therapeutics (NASDAQ RUBY) Earnings History by QuarterDateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails8/30/2019(Estimated) 5/15/20193/31/2019($0.38)($0.42)($0.42)ViewN/A3/28/201912/31/2018($0.42)($0.35)($0.35)ViewN/A11/13/2018Q3 2018($0.36)($0.42)($0.42)ViewN/A8/31/2018Q2 2018($0.60)($3.33)($3.33)ViewN/A(Earnings results data provided by Zacks Investment Research) This page was last updated on 5/21/2019 by MarketBeat.com StaffFeatured Article: Mutual Funds Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.
